John Bromels

John Bromels


John has found investing to be more interesting and profitable than collectible trading card games. He seeks growth and value stocks in the U.S., in Germany, and beyond!

Recent articles

Is 3M Healthy Enough to Invest In?

The company isn't going anywhere, that's for sure. But there's one yellow flag you need to know about before you buy in.

Did DuPont Just Ensure 3M's Future Dominance?

Through a merger with Dow Chemical, followed by a three-way split, DuPont hopes to improve its fortunes. But the big beneficiary might not be DuPont's shareholders: it might be 3M's.

The Biggest Risk for 3M Investors

3M is in good shape, but a looming legal nightmare could potentially destroy the company's success -- and reputation.